1. Home
  2. BALL vs DVA Comparison

BALL vs DVA Comparison

Compare BALL & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ball Corporation

BALL

Ball Corporation

HOLD

Current Price

$63.95

Market Cap

16.1B

Sector

Industrials

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$187.11

Market Cap

14.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BALL
DVA
Founded
1880
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Misc Health and Biotechnology Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.1B
14.9B
IPO Year
2009
2003

Fundamental Metrics

Financial Performance
Metric
BALL
DVA
Price
$63.95
$187.11
Analyst Decision
Buy
Buy
Analyst Count
15
8
Target Price
$71.57
★ $219.86
AVG Volume (30 Days)
★ 2.1M
477.7K
Earning Date
11-03-2026
11-02-2026
Dividend Yield
★ 1.27%
N/A
EPS Growth
N/A
★ N/A
EPS
1.59
★ 6.86
Revenue
N/A
★ $13,643,069,000.00
Revenue This Year
$13.36
$3.77
Revenue Next Year
$4.21
$3.39
P/E Ratio
$39.75
★ $27.21
Revenue Growth
N/A
★ 6.46
52 Week Low
$44.83
$101.00
52 Week High
$68.56
$247.49

Technical Indicators

Market Signals
Indicator
BALL
DVA
Relative Strength Index (RSI) 72.90 56.63
Support Level $60.25 $186.61
Resistance Level $63.99 $202.63
Average True Range (ATR) 1.24 3.82
MACD 0.89 1.44
Stochastic Oscillator 93.96 79.67

Price Performance

Historical Comparison
BALL
DVA

About BALL Ball Corporation

Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (48% of 2025 revenue), beverage packaging, EMEA (30%), beverage packaging, South America (16%)—and it generated $13 billion in revenue in 2025.

About DVA DaVita Inc.

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Share on Social Networks: